Optimum dose of olsalazine for maintaining remission in ulcerative colitis.

To evaluate the optimum dose of olsalazine for maintaining remission in ulcerative colitis, 198 patients in remission for more than three months were randomly assigned to receive 0.5 g, 1.0 g, or 2.0 g/day for 12 months. A dose-ranging effect was detected in the per protocol analysis, with remission...

Full description

Saved in:
Bibliographic Details
Main Authors: Travis, S P, Tysk, C, de Silva, H J, Sandberg-Gertzén, H, Jewell, D P, Järnerot, G
Format: Artigo
Language:Inglês
Published: 1994
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1375708/
https://ncbi.nlm.nih.gov/pubmed/7959238
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items